Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuromyelitis Optica | 59 | 2021 | 210 | 18.380 |
Why?
|
Aquaporin 4 | 25 | 2022 | 125 | 6.920 |
Why?
|
Autoantibodies | 20 | 2022 | 2008 | 3.000 |
Why?
|
Endosonography | 14 | 2020 | 576 | 2.500 |
Why?
|
Ganglia, Sympathetic | 3 | 2019 | 65 | 2.160 |
Why?
|
Immunologic Factors | 10 | 2020 | 1575 | 1.840 |
Why?
|
Pancreatic Neoplasms | 16 | 2022 | 5022 | 1.670 |
Why?
|
Multiple Sclerosis | 17 | 2019 | 3008 | 1.660 |
Why?
|
Siderosis | 5 | 2013 | 80 | 1.600 |
Why?
|
Iron Chelating Agents | 4 | 2019 | 143 | 1.440 |
Why?
|
Hemosiderosis | 2 | 2019 | 71 | 1.340 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2021 | 1521 | 1.190 |
Why?
|
Optic Neuritis | 6 | 2019 | 171 | 1.150 |
Why?
|
Methylprednisolone | 2 | 2019 | 400 | 1.130 |
Why?
|
Myelitis | 2 | 2019 | 54 | 1.120 |
Why?
|
Encephalomyelitis | 3 | 2019 | 34 | 1.080 |
Why?
|
Immunoglobulin G | 13 | 2022 | 4486 | 0.990 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 2 | 2019 | 34 | 0.900 |
Why?
|
Hemosiderin | 2 | 2011 | 46 | 0.860 |
Why?
|
Pancreatic Cyst | 2 | 2021 | 348 | 0.860 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2018 | 830 | 0.800 |
Why?
|
Neurodegenerative Diseases | 2 | 2019 | 958 | 0.760 |
Why?
|
Central Cord Syndrome | 1 | 2019 | 5 | 0.760 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2019 | 39 | 0.710 |
Why?
|
Celiac Plexus | 1 | 2018 | 26 | 0.710 |
Why?
|
Cyclobutanes | 1 | 2018 | 63 | 0.700 |
Why?
|
Pancreatic Pseudocyst | 3 | 2009 | 110 | 0.690 |
Why?
|
Plasma Exchange | 2 | 2019 | 153 | 0.690 |
Why?
|
Antigens, CD20 | 1 | 2019 | 209 | 0.680 |
Why?
|
Adenocarcinoma | 4 | 2019 | 6370 | 0.680 |
Why?
|
Poliomyelitis | 1 | 2019 | 97 | 0.670 |
Why?
|
Spinal Cord | 9 | 2019 | 1823 | 0.670 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 140 | 0.620 |
Why?
|
Pyridones | 2 | 2011 | 687 | 0.590 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 113 | 0.590 |
Why?
|
Neuromuscular Diseases | 1 | 2019 | 262 | 0.590 |
Why?
|
Ampulla of Vater | 1 | 2016 | 142 | 0.580 |
Why?
|
Jejunostomy | 1 | 2015 | 53 | 0.570 |
Why?
|
Demyelinating Diseases | 3 | 2015 | 371 | 0.570 |
Why?
|
Agranulocytosis | 1 | 2015 | 114 | 0.570 |
Why?
|
Mycophenolic Acid | 2 | 2017 | 345 | 0.570 |
Why?
|
Surgical Stomas | 1 | 2015 | 45 | 0.560 |
Why?
|
Immunosuppressive Agents | 5 | 2021 | 4208 | 0.550 |
Why?
|
Encephalitis | 1 | 2019 | 445 | 0.550 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2015 | 1062 | 0.540 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2019 | 713 | 0.540 |
Why?
|
Humans | 121 | 2022 | 717280 | 0.530 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2015 | 193 | 0.530 |
Why?
|
Myelitis, Transverse | 5 | 2019 | 41 | 0.530 |
Why?
|
Complement Pathway, Classical | 1 | 2014 | 105 | 0.520 |
Why?
|
Antibodies | 2 | 2019 | 2442 | 0.500 |
Why?
|
Varicose Veins | 1 | 2015 | 148 | 0.500 |
Why?
|
Complement C4 | 1 | 2014 | 273 | 0.490 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2009 | 753 | 0.480 |
Why?
|
Disability Evaluation | 7 | 2019 | 1826 | 0.480 |
Why?
|
Cholangitis, Sclerosing | 3 | 2021 | 160 | 0.470 |
Why?
|
Recurrence | 10 | 2019 | 8284 | 0.470 |
Why?
|
Patient Care | 1 | 2019 | 616 | 0.470 |
Why?
|
Disabled Persons | 2 | 2021 | 1149 | 0.470 |
Why?
|
Azathioprine | 1 | 2014 | 334 | 0.460 |
Why?
|
Benzamides | 1 | 2018 | 1414 | 0.460 |
Why?
|
Optic Nerve | 5 | 2019 | 556 | 0.460 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 322 | 0.460 |
Why?
|
Adrenal Cortex Hormones | 2 | 2019 | 1850 | 0.460 |
Why?
|
Cholangiocarcinoma | 3 | 2020 | 526 | 0.460 |
Why?
|
Bile Duct Neoplasms | 3 | 2020 | 580 | 0.460 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 641 | 0.450 |
Why?
|
Endoscopy, Digestive System | 2 | 2006 | 335 | 0.450 |
Why?
|
Nerve Block | 1 | 2018 | 638 | 0.440 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1030 | 0.430 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 791 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 19 | 2019 | 34503 | 0.430 |
Why?
|
Insulinoma | 1 | 2011 | 114 | 0.430 |
Why?
|
Middle Aged | 52 | 2022 | 215054 | 0.410 |
Why?
|
Female | 68 | 2022 | 377934 | 0.410 |
Why?
|
Male | 63 | 2022 | 351399 | 0.400 |
Why?
|
Central Nervous System Diseases | 2 | 2013 | 531 | 0.390 |
Why?
|
Vaccines | 1 | 2018 | 735 | 0.390 |
Why?
|
Lymph Nodes | 3 | 2020 | 3433 | 0.390 |
Why?
|
Adult | 47 | 2022 | 212470 | 0.370 |
Why?
|
Immunotherapy | 4 | 2019 | 4137 | 0.370 |
Why?
|
Treatment Outcome | 21 | 2022 | 62344 | 0.360 |
Why?
|
Retrospective Studies | 27 | 2021 | 72608 | 0.360 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1801 | 0.360 |
Why?
|
Aged | 35 | 2022 | 162862 | 0.360 |
Why?
|
Gastritis, Hypertrophic | 1 | 2008 | 9 | 0.350 |
Why?
|
Ablation Techniques | 1 | 2011 | 232 | 0.350 |
Why?
|
Cholestasis, Extrahepatic | 2 | 2008 | 50 | 0.350 |
Why?
|
Brain | 10 | 2019 | 25281 | 0.340 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 4 | 2021 | 490 | 0.330 |
Why?
|
Pancreatic Diseases | 2 | 2021 | 359 | 0.320 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 5101 | 0.310 |
Why?
|
Vitamin D Deficiency | 2 | 2019 | 1369 | 0.300 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15271 | 0.300 |
Why?
|
Jaundice | 2 | 2021 | 86 | 0.290 |
Why?
|
Vaccination | 1 | 2018 | 2963 | 0.290 |
Why?
|
Neutrophils | 1 | 2018 | 3816 | 0.280 |
Why?
|
Young Adult | 17 | 2019 | 56249 | 0.280 |
Why?
|
Glucocorticoids | 1 | 2015 | 2108 | 0.280 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1388 | 0.280 |
Why?
|
Health Care Costs | 1 | 2019 | 3179 | 0.280 |
Why?
|
Quality of Life | 5 | 2021 | 11758 | 0.280 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58528 | 0.270 |
Why?
|
Ethanol | 1 | 2011 | 1260 | 0.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3698 | 0.260 |
Why?
|
Ultrasonography, Interventional | 2 | 2020 | 1486 | 0.260 |
Why?
|
Central Nervous System | 2 | 2016 | 1292 | 0.250 |
Why?
|
Biopsy | 4 | 2019 | 6753 | 0.250 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9578 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 2938 | 0.250 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1814 | 0.240 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 13276 | 0.240 |
Why?
|
Inflammation | 3 | 2021 | 10116 | 0.240 |
Why?
|
Adolescent | 18 | 2019 | 85143 | 0.240 |
Why?
|
Internationality | 2 | 2019 | 997 | 0.240 |
Why?
|
Brain Diseases | 1 | 2012 | 1544 | 0.230 |
Why?
|
Liver | 2 | 2020 | 7628 | 0.230 |
Why?
|
Vitamin D | 2 | 2019 | 3164 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3385 | 0.230 |
Why?
|
Biliary Tract Neoplasms | 1 | 2004 | 176 | 0.220 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2004 | 195 | 0.220 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9597 | 0.210 |
Why?
|
Cytidine | 1 | 2021 | 69 | 0.210 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2019 | 66 | 0.210 |
Why?
|
Child | 14 | 2019 | 74388 | 0.210 |
Why?
|
Age of Onset | 3 | 2018 | 3333 | 0.200 |
Why?
|
Stents | 5 | 2022 | 3309 | 0.200 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10376 | 0.200 |
Why?
|
Ships | 1 | 2020 | 64 | 0.200 |
Why?
|
Gastric Balloon | 1 | 2020 | 30 | 0.200 |
Why?
|
Dihematoporphyrin Ether | 1 | 2019 | 31 | 0.200 |
Why?
|
Drainage | 3 | 2020 | 1139 | 0.190 |
Why?
|
Cholecystostomy | 1 | 2019 | 44 | 0.190 |
Why?
|
Enterovirus D, Human | 1 | 2019 | 5 | 0.190 |
Why?
|
Oligoclonal Bands | 1 | 2019 | 14 | 0.190 |
Why?
|
Biliary Tract Diseases | 2 | 2018 | 161 | 0.180 |
Why?
|
Cholecystitis, Acute | 1 | 2019 | 65 | 0.180 |
Why?
|
Child, Preschool | 8 | 2019 | 41221 | 0.180 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 40 | 0.180 |
Why?
|
Complement C5 | 1 | 2019 | 117 | 0.180 |
Why?
|
Biopsy, Fine-Needle | 2 | 2020 | 1063 | 0.180 |
Why?
|
Area Postrema | 1 | 2018 | 10 | 0.180 |
Why?
|
Swine | 3 | 2018 | 5821 | 0.180 |
Why?
|
Receptors, Interleukin-8B | 1 | 2018 | 65 | 0.180 |
Why?
|
Egypt | 1 | 2018 | 96 | 0.180 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 225 | 0.180 |
Why?
|
Enterovirus Infections | 1 | 2019 | 70 | 0.170 |
Why?
|
Cholestasis | 1 | 2021 | 361 | 0.170 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2007 | 1059 | 0.170 |
Why?
|
Pancreatic Ducts | 1 | 2020 | 335 | 0.170 |
Why?
|
Brachytherapy | 1 | 2006 | 1288 | 0.170 |
Why?
|
RNA, Messenger | 3 | 2021 | 13301 | 0.170 |
Why?
|
JC Virus | 1 | 2018 | 96 | 0.160 |
Why?
|
Disease Progression | 6 | 2020 | 13308 | 0.160 |
Why?
|
Secondary Prevention | 3 | 2019 | 1514 | 0.160 |
Why?
|
Rats, Inbred Lew | 1 | 2018 | 1174 | 0.160 |
Why?
|
Double-Blind Method | 3 | 2020 | 11910 | 0.150 |
Why?
|
Registries | 1 | 2013 | 8095 | 0.150 |
Why?
|
Incidental Findings | 1 | 2021 | 667 | 0.150 |
Why?
|
Haiti | 1 | 2018 | 543 | 0.150 |
Why?
|
Remission Induction | 2 | 2014 | 2391 | 0.140 |
Why?
|
Smad4 Protein | 1 | 2016 | 168 | 0.140 |
Why?
|
Time Factors | 5 | 2018 | 41094 | 0.140 |
Why?
|
Electrodes | 1 | 2018 | 597 | 0.140 |
Why?
|
Drugs, Investigational | 1 | 2018 | 234 | 0.140 |
Why?
|
Prospective Studies | 6 | 2020 | 51277 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 416 | 0.140 |
Why?
|
Spinal Cord Diseases | 1 | 2017 | 295 | 0.130 |
Why?
|
Postpartum Period | 2 | 2019 | 982 | 0.130 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2016 | 146 | 0.130 |
Why?
|
Gastric Mucosa | 2 | 2008 | 606 | 0.130 |
Why?
|
Vomiting | 2 | 2018 | 628 | 0.130 |
Why?
|
Retinal Neurons | 1 | 2015 | 71 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 996 | 0.130 |
Why?
|
Plasma | 1 | 2018 | 573 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14904 | 0.130 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 672 | 0.130 |
Why?
|
Hiccup | 1 | 2013 | 8 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1160 | 0.130 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3100 | 0.130 |
Why?
|
Age Factors | 3 | 2018 | 18798 | 0.130 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1826 | 0.130 |
Why?
|
Stromal Cells | 1 | 2019 | 1362 | 0.130 |
Why?
|
Genes, p53 | 1 | 2016 | 768 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39302 | 0.120 |
Why?
|
Neuralgia | 1 | 2019 | 520 | 0.120 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18353 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2661 | 0.120 |
Why?
|
Photochemotherapy | 1 | 2019 | 829 | 0.120 |
Why?
|
Palliative Care | 2 | 2006 | 3291 | 0.120 |
Why?
|
Pilot Projects | 2 | 2019 | 8068 | 0.120 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2016 | 876 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2019 | 13613 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 252 | 0.110 |
Why?
|
Antigens, Ly | 1 | 2013 | 304 | 0.110 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2011 | 41 | 0.110 |
Why?
|
Drug Design | 1 | 2018 | 1107 | 0.110 |
Why?
|
Autoantigens | 1 | 2016 | 911 | 0.110 |
Why?
|
Diazoxide | 1 | 2011 | 59 | 0.110 |
Why?
|
Analgesics | 1 | 2019 | 1023 | 0.110 |
Why?
|
Animals | 11 | 2018 | 170894 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6542 | 0.110 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11200 | 0.110 |
Why?
|
Survival Analysis | 3 | 2020 | 10542 | 0.110 |
Why?
|
Auditory Pathways | 1 | 2013 | 228 | 0.100 |
Why?
|
Tinnitus | 1 | 2013 | 166 | 0.100 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12435 | 0.100 |
Why?
|
Calcifediol | 1 | 2011 | 170 | 0.100 |
Why?
|
Research Design | 2 | 2018 | 5883 | 0.100 |
Why?
|
Antibody Formation | 1 | 2015 | 1423 | 0.100 |
Why?
|
Cohort Studies | 6 | 2020 | 39891 | 0.100 |
Why?
|
Tomography, Optical Coherence | 4 | 2019 | 2494 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 3016 | 0.100 |
Why?
|
Behavior, Animal | 1 | 2018 | 1915 | 0.100 |
Why?
|
Colectomy | 1 | 2015 | 650 | 0.100 |
Why?
|
Postmortem Changes | 1 | 2010 | 129 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3968 | 0.090 |
Why?
|
Myelin Sheath | 1 | 2013 | 650 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2013 | 709 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2935 | 0.090 |
Why?
|
Mood Disorders | 1 | 2016 | 1105 | 0.090 |
Why?
|
Risk Factors | 4 | 2021 | 70863 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1671 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8925 | 0.090 |
Why?
|
Auditory Perception | 1 | 2013 | 520 | 0.090 |
Why?
|
Protein-Losing Enteropathies | 1 | 2008 | 47 | 0.090 |
Why?
|
Risk Assessment | 3 | 2018 | 23543 | 0.080 |
Why?
|
Brain Stem | 1 | 2013 | 840 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2951 | 0.080 |
Why?
|
Mobility Limitation | 1 | 2011 | 398 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2678 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 22929 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3532 | 0.080 |
Why?
|
Iridium Radioisotopes | 1 | 2006 | 28 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 774 | 0.080 |
Why?
|
Gastroscopy | 1 | 2008 | 200 | 0.080 |
Why?
|
Seroepidemiologic Studies | 1 | 2008 | 378 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1787 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3070 | 0.070 |
Why?
|
Cholangiography | 1 | 2006 | 189 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2010 | 2407 | 0.070 |
Why?
|
Adenoma, Islet Cell | 1 | 2005 | 83 | 0.070 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2005 | 38 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5465 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2018 | 16020 | 0.070 |
Why?
|
Seasons | 1 | 2011 | 1431 | 0.070 |
Why?
|
Retinal Ganglion Cells | 1 | 2011 | 772 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4928 | 0.070 |
Why?
|
Decision Making | 1 | 2019 | 3848 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 2943 | 0.070 |
Why?
|
Cystadenoma, Serous | 1 | 2005 | 101 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1909 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2010 | 1711 | 0.070 |
Why?
|
Hypoglycemia | 1 | 2011 | 809 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2198 | 0.070 |
Why?
|
Cognition Disorders | 2 | 2018 | 3990 | 0.070 |
Why?
|
Histocytological Preparation Techniques | 1 | 2004 | 30 | 0.070 |
Why?
|
Retina | 2 | 2013 | 2651 | 0.070 |
Why?
|
Pliability | 1 | 2004 | 58 | 0.070 |
Why?
|
Tissue and Organ Harvesting | 1 | 2007 | 363 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7177 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3565 | 0.060 |
Why?
|
Mutation | 2 | 2021 | 29491 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10661 | 0.060 |
Why?
|
Video Recording | 1 | 2009 | 949 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2020 | 4921 | 0.060 |
Why?
|
Plastics | 1 | 2004 | 122 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2011 | 744 | 0.060 |
Why?
|
Prognosis | 5 | 2021 | 29226 | 0.060 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2007 | 483 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2830 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3274 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2007 | 955 | 0.060 |
Why?
|
Proton Pump Inhibitors | 1 | 2008 | 478 | 0.060 |
Why?
|
Pancreas | 2 | 2021 | 1693 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7486 | 0.060 |
Why?
|
Infant | 2 | 2017 | 34574 | 0.060 |
Why?
|
Comorbidity | 1 | 2017 | 10452 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 23409 | 0.060 |
Why?
|
Peptides | 1 | 2015 | 4438 | 0.060 |
Why?
|
Pregnancy | 3 | 2019 | 27304 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2008 | 1679 | 0.060 |
Why?
|
Antigens, CD | 1 | 2013 | 4157 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20435 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4102 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8013 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 21811 | 0.050 |
Why?
|
Rats | 1 | 2018 | 25092 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2014 | 2951 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2019 | 24744 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5028 | 0.050 |
Why?
|
Culture Media | 1 | 2022 | 952 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5160 | 0.050 |
Why?
|
Materials Testing | 1 | 2004 | 873 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13716 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 3707 | 0.050 |
Why?
|
Mice | 4 | 2016 | 81128 | 0.050 |
Why?
|
Metals | 1 | 2004 | 694 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2955 | 0.050 |
Why?
|
Cladribine | 1 | 2019 | 32 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1048 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2020 | 288 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 14899 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1121 | 0.040 |
Why?
|
Gallbladder | 1 | 2019 | 308 | 0.040 |
Why?
|
Consensus | 1 | 2007 | 2755 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 9754 | 0.040 |
Why?
|
Minnesota | 1 | 2018 | 377 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2019 | 396 | 0.040 |
Why?
|
Visual Acuity | 2 | 2019 | 2502 | 0.040 |
Why?
|
Organoids | 1 | 2022 | 678 | 0.040 |
Why?
|
Databases, Factual | 1 | 2012 | 7847 | 0.040 |
Why?
|
Blood Glucose | 1 | 2011 | 6296 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 761 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2019 | 776 | 0.040 |
Why?
|
Expert Testimony | 1 | 2018 | 359 | 0.040 |
Why?
|
Syndrome | 2 | 2015 | 3201 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2016 | 304 | 0.040 |
Why?
|
Catheterization | 1 | 2021 | 1455 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2005 | 1535 | 0.040 |
Why?
|
Nausea | 1 | 2018 | 658 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2019 | 1377 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3631 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2006 | 2572 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 610 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1195 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2018 | 1845 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1854 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 959 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5278 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1744 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2018 | 6929 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11777 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 2046 | 0.030 |
Why?
|
Vision Tests | 1 | 2013 | 155 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8376 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1758 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5948 | 0.030 |
Why?
|
Pancreatitis | 2 | 2011 | 1064 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2816 | 0.030 |
Why?
|
Body Composition | 1 | 2021 | 2399 | 0.030 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2011 | 78 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 2004 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1420 | 0.030 |
Why?
|
Chronic Disease | 1 | 2007 | 9047 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3703 | 0.030 |
Why?
|
Serologic Tests | 1 | 2013 | 383 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 975 | 0.030 |
Why?
|
Headache | 1 | 2019 | 1152 | 0.030 |
Why?
|
Phenotype | 2 | 2019 | 16404 | 0.030 |
Why?
|
Lymphocytes | 1 | 2019 | 2748 | 0.030 |
Why?
|
Up-Regulation | 1 | 2020 | 4356 | 0.030 |
Why?
|
Spleen | 1 | 2016 | 2473 | 0.020 |
Why?
|
North America | 1 | 2013 | 1196 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 753 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9927 | 0.020 |
Why?
|
United States | 2 | 2020 | 67804 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 1740 | 0.020 |
Why?
|
Japan | 1 | 2013 | 1367 | 0.020 |
Why?
|
Macular Edema | 1 | 2013 | 339 | 0.020 |
Why?
|
Survival Rate | 1 | 2004 | 13262 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2495 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4286 | 0.020 |
Why?
|
Duodenum | 1 | 2011 | 473 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2103 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2008 | 205 | 0.020 |
Why?
|
Stomach | 1 | 2011 | 674 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2016 | 2332 | 0.020 |
Why?
|
Dyspepsia | 1 | 2007 | 92 | 0.020 |
Why?
|
Body Water | 1 | 2008 | 348 | 0.020 |
Why?
|
Cochlea | 1 | 2013 | 777 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2008 | 327 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3349 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3429 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 6134 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6199 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 20097 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9773 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 2113 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3083 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8685 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9532 | 0.020 |
Why?
|
Axons | 1 | 2011 | 1742 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2669 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16989 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2008 | 1003 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3421 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2005 | 419 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2657 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 2037 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1030 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 8944 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4260 | 0.010 |
Why?
|
Astrocytes | 1 | 2008 | 1253 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10802 | 0.010 |
Why?
|
Laparoscopy | 1 | 2011 | 1995 | 0.010 |
Why?
|
Protein Conformation | 1 | 2008 | 4072 | 0.010 |
Why?
|
Models, Neurological | 1 | 2008 | 1778 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6282 | 0.010 |
Why?
|
Models, Molecular | 1 | 2008 | 5542 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 14243 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2008 | 3433 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18738 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2005 | 15126 | 0.000 |
Why?
|